Medical Predictive Science Corp. (MPSC) was founded with the mission to advance healthcare through innovative computational diagnostics and bioinformatics. Their flagship product, the Heart Rate Observation System (HeRO), is a predictive monitoring system designed to provide early warnings for diseases in premature infants. By focusing on neonatal care, MPSC aims to improve outcomes for vulnerable newborns through advanced technology and data-driven insights.
Notable affiliations include partnerships with the Stanley Manne Children’s Research Institute and Ann & Robert H. Lurie Children’s Hospital of Chicago. Key achievements include contributing to UAB Medicine's Guinness World Record for the most premature surviving infant. MPSC's impact is significant in neonatal care, providing critical early warnings that enhance medical responses and potentially save lives.
Quick Facts
When was Medical Predictive Science's last funding round?
Medical Predictive Science's most recent funding round was for $1.3M (USD) in January 2010.
How much disclosed funding has Medical Predictive Science raised?
As of Jan 27, 2010, Medical Predictive Science has disclosed funding of $1.3M (USD).